New Nordic Healthbrands 미래 성장

Future 기준 확인 0/6

현재 New Nordic Healthbrands 의 성장과 수익을 예측할 만큼 분석가의 범위가 충분하지 않습니다.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Personal Products 수익 성장	8.0%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	None
마지막 업데이트	n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

New Nordic Healthbrands (STO:NNH) Is Carrying A Fair Bit Of Debt

Nov 05

New Nordic Healthbrands AB (publ)'s (STO:NNH) Popularity With Investors Is Clear

Jul 03

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

Oct 30

New Nordic Healthbrands (STO:NNH) Will Be Hoping To Turn Its Returns On Capital Around

Jul 31

Calculating The Intrinsic Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Jun 08

Estimating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Mar 08

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

Feb 15

What Do The Returns On Capital At New Nordic Healthbrands (STO:NNH) Tell Us?

Jan 25

Should New Nordic Healthbrands AB (publ) (STO:NNH) Be Part Of Your Dividend Portfolio?

Dec 31

New Nordic Healthbrands AB (publ)'s (STO:NNH) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Dec 09

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 New Nordic Healthbrands 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

OM:NNH - 애널리스트의 미래 추정치 및 과거 재무 데이터 (SEK Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
9/30/2024	543	-15	-12	-7	N/A
6/30/2024	549	-12	-9	-6	N/A
3/31/2024	538	-10	2	5	N/A
12/31/2023	534	-6	25	28	N/A
9/30/2023	503	-4	18	21	N/A
6/30/2023	490	1	15	18	N/A
3/31/2023	490	-3	-8	-5	N/A
12/31/2022	488	-3	-18	-15	N/A
9/30/2022	497	-4	-31	-28	N/A
6/30/2022	500	-4	-26	-23	N/A
3/31/2022	510	12	-16	-12	N/A
12/31/2021	515	21	-11	-8	N/A
9/30/2021	512	28	14	15	N/A
6/30/2021	502	28	11	11	N/A
3/31/2021	466	23	21	21	N/A
12/31/2020	450	18	18	20	N/A
9/30/2020	447	20	10	13	N/A
6/30/2020	449	25	12	15	N/A
3/31/2020	461	27	-11	-8	N/A
12/31/2019	453	28	-2	-1	N/A
9/30/2019	436	31	9	10	N/A
6/30/2019	430	30	14	14	N/A
3/31/2019	409	28	21	22	N/A
12/31/2018	394	27	17	18	N/A
9/30/2018	383	26	15	16	N/A
6/30/2018	358	22	N/A	14	N/A
3/31/2018	352	23	N/A	30	N/A
12/31/2017	345	20	N/A	26	N/A
9/30/2017	329	14	N/A	1	N/A
6/30/2017	325	12	N/A	-2	N/A
3/31/2017	312	10	N/A	-7	N/A
12/31/2016	306	10	N/A	-9	N/A
9/30/2016	310	12	N/A	4	N/A
6/30/2016	300	10	N/A	5	N/A
3/31/2016	300	11	N/A	-2	N/A
12/31/2015	298	11	N/A	-3	N/A
9/30/2015	294	12	N/A	-6	N/A
6/30/2015	285	13	N/A	-5	N/A
3/31/2015	284	13	N/A	-2	N/A
12/31/2014	272	12	N/A	3	N/A
9/30/2014	261	10	N/A	5	N/A
6/30/2014	254	7	N/A	6	N/A
3/31/2014	238	7	N/A	4	N/A
12/31/2013	228	6	N/A	0	N/A

애널리스트 미래 성장 예측

수입 대 저축률: NNH 의 예상 수익 증가율이 절약률( 1.2% )보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: NNH 의 수익이 Swedish 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: NNH 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: NNH 의 수익이 Swedish 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: NNH 의 수익이 연간 20% 보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: NNH 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

New Nordic Healthbrands 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Recent updates

New Nordic Healthbrands (STO:NNH) Is Carrying A Fair Bit Of Debt

Third quarter 2024 earnings released: kr0.28 loss per share (vs kr0.33 profit in 3Q 2023)

New major risk - Market cap size

Second quarter 2024 earnings released: kr0.72 loss per share (vs kr0.50 loss in 2Q 2023)

New Nordic Healthbrands AB (publ)'s (STO:NNH) Popularity With Investors Is Clear

First quarter 2024 earnings released: kr0.55 loss per share (vs kr0.094 profit in 1Q 2023)

New Nordic Healthbrands AB (publ) to Report Fiscal Year 2024 Results on Feb 28, 2025

New Nordic Healthbrands (STO:NNH) Is Making Moderate Use Of Debt

Third quarter 2023 earnings released: EPS: kr0.33 (vs kr1.16 in 3Q 2022)

New major risk - Market cap size

New Nordic Healthbrands AB (publ) Part Ways with Tage Juhl Finninge, Chief Commercial and Operating Officer

Does New Nordic Healthbrands (STO:NNH) Have A Healthy Balance Sheet?

Second quarter 2023 earnings released: kr0.50 loss per share (vs kr1.21 loss in 2Q 2022)

Is New Nordic Healthbrands (STO:NNH) A Risky Investment?

First quarter 2023 earnings released: EPS: kr0.094 (vs kr0.16 in 1Q 2022)

Chief Commercial Officer & COO recently bought kr140k worth of stock

Full year 2022 earnings released: kr0.46 loss per share (vs kr3.44 profit in FY 2021)

Chief Commercial Officer & COO recently bought kr202k worth of stock

Chief Commercial Officer & COO recently bought kr103k worth of stock

Is New Nordic Healthbrands (STO:NNH) Using Too Much Debt?

No independent directors

Third quarter 2022 earnings released: EPS: kr1.16 (vs kr1.08 in 3Q 2021)

Investor sentiment improved over the past week

New Nordic Healthbrands AB (publ) Appoints Tage Juhl Finninge as New Chief Commercial and Operating Officer

Now 24% undervalued after recent price drop

Calculating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Now 20% undervalued after recent price drop

Capital Allocation Trends At New Nordic Healthbrands (STO:NNH) Aren't Ideal

Investor sentiment deteriorated over the past week

New Nordic Healthbrands (STO:NNH) Has A Pretty Healthy Balance Sheet

Investor sentiment improved over the past week

Director recently bought kr102k worth of stock

Director recently bought kr91k worth of stock

Investor sentiment deteriorated over the past week

Capital Investment Trends At New Nordic Healthbrands (STO:NNH) Look Strong

No independent directors

Upcoming dividend of kr1.25 per share

Co-Founder recently sold kr316k worth of stock

Full year 2021 earnings released: EPS: kr3.44 (vs kr2.87 in FY 2020)

Director recently bought kr123k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Is New Nordic Healthbrands (STO:NNH) Using Too Much Debt?

Co-Founder recently sold kr386k worth of stock

Co-Founder recently sold kr378k worth of stock

Co-Founder recently sold kr196k worth of stock

Co-Founder recently sold kr155k worth of stock

Investor sentiment deteriorated over the past week

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

Co-Founder recently sold kr147k worth of stock

Second quarter 2021 earnings released: EPS kr1.41 (vs kr0.53 in 2Q 2020)

New Nordic Healthbrands (STO:NNH) Will Be Hoping To Turn Its Returns On Capital Around

Investor sentiment improved over the past week

Calculating The Intrinsic Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Investor sentiment improved over the past week

Upcoming dividend of kr1.50 per share

Full year 2020 earnings released: EPS kr2.87 (vs kr4.53 in FY 2019)

Estimating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Full year 2020 earnings released: EPS kr2.87 (vs kr4.53 in FY 2019)

New 90-day low: kr55.80

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

What Do The Returns On Capital At New Nordic Healthbrands (STO:NNH) Tell Us?

Should New Nordic Healthbrands AB (publ) (STO:NNH) Be Part Of Your Dividend Portfolio?

New Nordic Healthbrands AB (publ)'s (STO:NNH) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

New 90-day low: kr56.00

Third quarter 2020 earnings released: EPS kr1.04

New 90-day low: kr56.20

New 90-day low - kr56.80

New 90-day high - kr67.00

New Nordic Healthbrands AB (publ) to Report First Half, 2020 Results on Jul 31, 2020

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견